Arkolith/Insider Trading/RCKT/Form 4

Bjork Elisabeth

DirectorROCKET PHARMACEUTICALS, INC. (RCKT) · full profile →Form 4 · filed Jan 6, 2026
Net Buying
Open-Market Buys
$34K
Open-Market Sells
$0
Net Open-Market Flow
$34K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jan 2, 2026Buy(P)10K$3.44$34K50K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001140361-26-000378) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML